2024 - Criticality of STAT Osmolality Testing: Identifying Toxic Alcohol Ingestion
Date2024-09-13
Deadline2024-09-13
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Medical Device; Medical Device Diagnostics
Topics/Call fo Papers
Discover an informative webinar that provides an in-depth exploration of osmolality testing, explains what it is and how it can be effectively utilized in medical diagnostics.
In this webinar, a nephrologist will discuss the clinical significance of STAT Osmolality testing to support the diagnosis of toxic alcohol ingestion. They will discuss the process of how osmolality is tested, highlighting the key role that blood plasma osmolality testing plays in the diagnosis and management of patients.
Attendees will learn the key differences between calculated and measured osmolality, as well as how to use the osmolar gap to aid in diagnosing ingestions of toxic alcohols such as ethylene glycol. The discussion will focus on the urgency of swiftly performing osmolality measurements to facilitate prompt treatment for patients who have ingested toxic substances.
Reinforcing the utility of osmolality testing with real-world applications, the expert speaker will also explain the differences between calculated and measured osmolality and how they can be used together to support life-saving patient intervention. Further emphasizing its impact, the speaker will explain the speed with which the osmolality measurement must be made to inform timely decision-making that influences the best patient outcomes.
Moreover, the webinar will also focus on the future of testing methods for evaluating possible toxic alcohol ingestion, providing insights into emerging technologies and techniques that could enhance diagnostic accuracy and patient care.
Register for this webinar today to understand the critical role of osmolality testing in medical diagnostics, particularly for the urgent diagnosis and management of toxic alcohol ingestion.
Keywords: Toxicity, Diagnostic Test, Clinical Research, Clinical Laboratory, Pathology, Toxicology, Diagnostics, Laboratory Testing, Laboratory Technology, Nephrology, Basic Research
In this webinar, a nephrologist will discuss the clinical significance of STAT Osmolality testing to support the diagnosis of toxic alcohol ingestion. They will discuss the process of how osmolality is tested, highlighting the key role that blood plasma osmolality testing plays in the diagnosis and management of patients.
Attendees will learn the key differences between calculated and measured osmolality, as well as how to use the osmolar gap to aid in diagnosing ingestions of toxic alcohols such as ethylene glycol. The discussion will focus on the urgency of swiftly performing osmolality measurements to facilitate prompt treatment for patients who have ingested toxic substances.
Reinforcing the utility of osmolality testing with real-world applications, the expert speaker will also explain the differences between calculated and measured osmolality and how they can be used together to support life-saving patient intervention. Further emphasizing its impact, the speaker will explain the speed with which the osmolality measurement must be made to inform timely decision-making that influences the best patient outcomes.
Moreover, the webinar will also focus on the future of testing methods for evaluating possible toxic alcohol ingestion, providing insights into emerging technologies and techniques that could enhance diagnostic accuracy and patient care.
Register for this webinar today to understand the critical role of osmolality testing in medical diagnostics, particularly for the urgent diagnosis and management of toxic alcohol ingestion.
Keywords: Toxicity, Diagnostic Test, Clinical Research, Clinical Laboratory, Pathology, Toxicology, Diagnostics, Laboratory Testing, Laboratory Technology, Nephrology, Basic Research
Other CFPs
- Streamlining Clinical Trial Imaging Workflows: From Collection to Completion
- How Artificial Intelligence is Transforming Clinical Development
- Changes are Coming to Prefilled Injectable Drug Delivery Systems
- Clinical Data Analysis: Avoiding Obstacles to Success
- Advanced AAV Processing and Potency through Characterisation of Capsid and Payload Heterogeneity
Last modified: 2024-08-09 03:24:00